Member of the Association of American Physicians
His primary areas of study are Pulmonary hypertension, Pathology, Lung, Internal medicine and Endothelial stem cell. His Pulmonary hypertension research incorporates elements of Pulmonary pathology, Respiratory disease, Hypoxia, Pulmonary artery and Endothelium. His research integrates issues of Nephrology, Neovascularization, Bilateral Nephrectomy, Cell growth and Kidney disease in his study of Pathology.
The concepts of his Lung study are interwoven with issues in Immunology, Pathogenesis and Prostacyclin. His research in Internal medicine intersects with topics in Endocrinology and Cardiology. His work carried out in the field of Endothelial stem cell brings together such families of science as Vascular endothelial growth factor A and Angiogenesis.
His primary areas of investigation include Internal medicine, Pulmonary hypertension, Lung, Cardiology and Pathology. His studies link Endocrinology with Internal medicine. His Pulmonary hypertension research includes themes of Endothelial stem cell, Respiratory disease, Pulmonary pathology, Pathogenesis and Pulmonary artery.
He combines subjects such as Endothelium and Angiogenesis with his study of Endothelial stem cell. His studies deal with areas such as Anesthesia, COPD, Immunology and Pharmacology as well as Lung. His Pathology research is multidisciplinary, incorporating perspectives in Apoptosis and Vascular endothelial growth factor.
Norbert F. Voelkel focuses on Internal medicine, Pulmonary hypertension, Cardiology, Lung and Pathology. His Internal medicine study frequently involves adjacent topics like Endocrinology. His Pulmonary hypertension study integrates concerns from other disciplines, such as Vascular disease, Hypoxia, Disease and Pulmonary artery.
The various areas that Norbert F. Voelkel examines in his Cardiology study include Blockade and Anakinra. His Lung research also works with subjects such as
Norbert F. Voelkel mainly focuses on Internal medicine, Pulmonary hypertension, Cardiology, Immunology and Lung. His research is interdisciplinary, bridging the disciplines of Endocrinology and Internal medicine. Norbert F. Voelkel interconnects Gene expression and Right ventricular hypertrophy in the investigation of issues within Endocrinology.
His studies in Pulmonary hypertension integrate themes in fields like Pulmonary pathology, Pathology, Complication, Pulmonary artery and Muscle hypertrophy. His biological study spans a wide range of topics, including COPD, Vascular endothelial growth factor, Immune system and Gene silencing. The Vascular endothelial growth factor study which covers Angiogenesis that intersects with Vascular endothelial growth factor A.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cellular and molecular pathobiology of pulmonary arterial hypertension.
Marc Humbert;Nicholas W Morrell;Stephen L Archer;Kurt R Stenmark.
Journal of the American College of Cardiology (2004)
Inhibition of VEGF receptors causes lung cell apoptosis and emphysema
Yasunori Kasahara;Rubin M. Tuder;Laimute Taraseviciene-Stewart;Timothy D. Le Cras.
Journal of Clinical Investigation (2000)
Right Ventricular Function and Failure Report of a National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure
Norbert F. Voelkel;Robert A. Quaife;Leslie A. Leinwand;Robyn J. Barst.
Prostacyclin Synthase Expression Is Decreased in Lungs from Patients with Severe Pulmonary Hypertension
Rubin M. Tuder;Carlyne D. Cool;Mark W. Geraci;Jun Wang.
American Journal of Respiratory and Critical Care Medicine (1999)
Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension
R. M. Tuder;B. Groves;D. B. Badesch;N. F. Voelkel.
American Journal of Pathology (1994)
Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension
Laimute Taraseviciene-Stewart;Yasunori Kasahara;Lori Alger;Peter Hirth.
The FASEB Journal (2001)
Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema.
Yasunori Kasahara;Rubin M. Tuder;Carlyne D. Cool;David A. Lynch.
American Journal of Respiratory and Critical Care Medicine (2001)
The Right Ventricle Under Pressure: Cellular and Molecular Mechanisms of Right-Heart Failure in Pulmonary Hypertension
Harm J. Bogaard;Kohtaro Abe;Anton Vonk Noordegraaf;Norbert F. Voelkel.
Inflammation, growth factors, and pulmonary vascular remodeling.
Paul M. Hassoun;Luc Mouthon;Joan A. Barberà;Saadia Eddahibi.
Journal of the American College of Cardiology (2009)
Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide.
R M Tuder;B E Flook;N F Voelkel.
Journal of Clinical Investigation (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: